Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

703 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.
Jakubowski JA, Erlinge D, Alexopoulos D, Small DS, Winters KJ, Gurbel PA, Angiolillo DJ. Jakubowski JA, et al. Among authors: angiolillo dj. Am J Cardiovasc Drugs. 2017 Apr;17(2):109-121. doi: 10.1007/s40256-016-0202-3. Am J Cardiovasc Drugs. 2017. PMID: 27854064 Review.
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.
Wiviott SD, Trenk D, Frelinger AL, O'Donoghue M, Neumann FJ, Michelson AD, Angiolillo DJ, Hod H, Montalescot G, Miller DL, Jakubowski JA, Cairns R, Murphy SA, McCabe CH, Antman EM, Braunwald E; PRINCIPLE-TIMI 44 Investigators. Wiviott SD, et al. Among authors: angiolillo dj. Circulation. 2007 Dec 18;116(25):2923-32. doi: 10.1161/CIRCULATIONAHA.107.740324. Epub 2007 Dec 3. Circulation. 2007. PMID: 18056526 Clinical Trial.
ADP receptor antagonism: what's in the pipeline?
Angiolillo DJ. Angiolillo DJ. Am J Cardiovasc Drugs. 2007;7(6):423-32. doi: 10.2165/00129784-200707060-00005. Am J Cardiovasc Drugs. 2007. PMID: 18076209 Review.
Antiplatelet therapy and platelet function testing. Introduction.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Braunwald E, et al. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I1. doi: 10.1002/clc.20370. Clin Cardiol. 2008. PMID: 18481815 Free PMC article. No abstract available.
Assessing the current role of platelet function testing.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Braunwald E, et al. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I10-6. doi: 10.1002/clc.20361. Clin Cardiol. 2008. PMID: 18481816 Free PMC article. Review.
Investigating the mechanisms of hyporesponse to antiplatelet approaches.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Braunwald E, et al. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I21-7. doi: 10.1002/clc.20360. Clin Cardiol. 2008. PMID: 18481819 Free PMC article. Review.
Antiplatelet therapy and platelet function testing.
Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S. Braunwald E, et al. Clin Cardiol. 2008 Mar;31(3 Suppl 1):I36. doi: 10.1002/clc.20371. Clin Cardiol. 2008. PMID: 18481821 Free PMC article. No abstract available.
703 results